Core Viewpoint - South Korean pharmaceutical and biotech companies are shifting from providing gold as a long-standing service award to cash payments due to the financial pressure caused by soaring international gold prices [1] Group 1: Industry Changes - The tradition of awarding gold to senior employees is being replaced by cash payments as companies face increased financial burdens [1] - The international spot gold price and New York Mercantile Exchange April gold futures both surpassed $5,500 per ounce, marking a historical high [1] Group 2: Price Trends - The price of international gold rose from $4,000 to $5,500 per ounce in less than three months [1] - At the beginning of 2024, the international gold price was just above $2,000 per ounce [1]
金价飞涨扛不住，韩国企业黄金奖励改成现金
Sou Hu Cai Jing·2026-01-30 05:56